SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, which affects one out of four people worldwide, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Over 20+ years of pharmacokinetic studies, we have accumulated normal and diseased tissues representing FLD with or without history of alcohol consumption and steatohepatitis in our Research Biobank.
As part of the Biobank, we have created a new fatty liver disease (FLD) progression infographic showing statistics and characteristics of tissues from normal states into steatosis, steatohepatitis and Non-alcoholic Steatohepatitis (NASH) into cirrhosis. Click here to view this new resource.
We also recently held a webinar on Drug Metabolizing Enzymes and Transporters in NASH. Click here to view this resource.
We have additionally begun offering human gallbladder tissue from matching donors with the human liver tissue samples. Furthermore, the Research Biobank donor information sheet now lists additional details, such as diabetes type, pediatric donors, and NASH donors have been listed in their own location with additional information for easier reference.
Learn more about:
*Hepatocytes have not been prepared for all donors. Please refer to the donor information sheet for availability.
About the Authors
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback